Iyadh Douagi

National Institutes of Health — United States

Immunology and Microbiology · Life Sciences

37h-index4.3kcitations107works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

T-cell and B-cell Immunology(14), Immune Cell Function and Interaction(14), HIV Research and Treatment(12), Immunotherapy and Immune Responses(11), Retinal Development and Disorders(8)

Publications107 total

Figure S12 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S10 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Table S2 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S1 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S13 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Data from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S6 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S5 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S8 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S4 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S7 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S15 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Table S3 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S14 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S11 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S9 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Table S1 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S2 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Figure S3 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity
2025Open Access
Leveraging optimized oligonucleotide-tagged antigen assemblies and single-cell sequencing for multiplexed proteogenomic profiling of human B cell reactivities
The Journal of Immunology·2025Open Access
page 1 of 6Next →

Frequent Co-authors

Gunilla B. Karlsson Hedestam(11), John R. Mascola(8), Peter Arner(8), Fredrik Lanner(7), Christopher Sundling(7), Ana Cumano(6), Jurga Laurencikiene(6), Mattias N.E. Forsell(6), Sarita Panula(5), Mikael Rydén(5), Karin Loré(5), Richard T. Wyatt(5), Mohsen Karimi(5), Sophie Petropoulos(4), Outi Hovatta(4), Cherrelle Dacon(4), Linghang Peng(4), Meng Yuan(4), Lingshu Wang(4), Ming Zhao(4)